Search Contract Opportunities

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)   14

ID: 75A50123C00040 • Type: Award Notice

Description

Develop a Kit for the administration of Nplate (Romiplostim) for treatment of Hematopoietic Syndrome Acute Radiation Syndrome (HS-ARS). Kit development will lead to an FDA approved combination product (Nplate medicine + medical devices for injection). The co-packaged combination product (e.g., Nplate drug and the Kit will be stockpiled separately) will enable commercial use of the Nplate drug in the U.S. and stockpiling of the Kit and Nplate by BARDA.

Overview

Awardee
amgen
Award ID
Reported Award
$7,290,924
Award Date
Aug. 22, 2023
Posted
Aug. 23, 2023, 1:27 p.m. EDT
Set Aside
None
Place of Performance
Washington, DC 20515 United States
Source
SAM

Current SBA Size Standard
1000 Employees
Pricing
Multiple Types Common
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) (75A50123C00040) was awarded to amgen on 8/23/23 by HHS Office of the Assistant Secretary for Preparedness and Response.
Primary Contact
Name
richard hall   Profile
Phone
None

Documents

Posted documents for Award Notice 75A50123C00040

Question & Answer

Opportunity Lifecycle

Procurement notices related to Award Notice 75A50123C00040

Award Notifications

Agency published notification of awards for Award Notice 75A50123C00040

Similar Active Opportunities

Open contract opportunities similar to Award Notice 75A50123C00040

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > ASPR OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
FPDS Organization Code
7505-75AN00
Source Organization Code
500024310
Last Updated
Sept. 6, 2023
Last Updated By
richard.hall@hhs.gov
Archive Date
Sept. 6, 2023